HomeContact UsSearchGenzyme Corporate
Our TrialsOur Trial ResultsAbout The Registry

Aldurazyme® (laronidase)

Bibliographical Information:

Drug Name

Generic Name

Studied Indications or Disease

Approved U.S. Drug Label

Aldurazyme®

laronidase

mucopolysaccharidosis I (MPS I)

Prescribing Info

Protocol BIO 7500-001

Kakkis ED, Muenzer J, Tiller G, Waber L, Belmont J, Passage M, et al. Enzyme-replacement therapy in mucopolysaccharidosis I. N Engl J Med 2001;344(3):182-88.

Protocol ALID-003-99

Wraith J, Clarke L, Beck M, Kolodny E, Pastores G, Muenzer J, et al. Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human α-L-iduronidase (lardonidase). J Pediatr 2004;144:581-8.


Search
 Go
Contact Information

Genzyme Corporation
500 Kendall Street
Cambridge, MA 02142
T:617 252 7500
F:617 252 7600
Contact Us
Notice of Information Practices | Terms and Conditions of Use | Privacy Policy   | © 2012 Genzyme Corporation, a Sanofi company. All rights reserved.